BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3678719)

  • 1. [Aztreonam in the treatment of nosocomial urinary infections].
    Nardini A; Taddei P; Rossi F
    G Ital Chemioter; 1986; 33(2-3):139-42. PubMed ID: 3678719
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
    LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
    Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of aztreonam in urinary tract infections.
    Roberts JA
    Urology; 1988 Jun; 31(6 Suppl):39-44. PubMed ID: 3287749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aztreonam: prevention of bacteremia in urologic surgery in patients with urinary infection].
    Dalet F; del Río G; Rabinad E
    Med Clin (Barc); 1988 Jan; 90(3):101-5. PubMed ID: 3352336
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections.
    Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B
    Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aztreonam in severe gram-negative infections in hospitalized patients. Clinical experience in Spain. Preliminary data].
    García-Rodríguez JA; Rabinad E
    Med Clin (Barc); 1987 Apr; 88(13):538-43. PubMed ID: 3586736
    [No Abstract]   [Full Text] [Related]  

  • 7. Aztreonam in the treatment of serious gram-negative infections in the elderly.
    Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A
    Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of aztreonam for complicated urinary tract infection].
    Moriguchi R; Yamagoshi T; Nagakubo I; Aoki S
    Hinyokika Kiyo; 1985 Sep; 31(9):1675-80. PubMed ID: 4083224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of aztreonam in patients suffering from urinary tract infections with contraindications for the use of aminoglycosides.
    Fraschini F; Scaglione F; Alessandria M; Gattei G
    Chemioterapia; 1986 Oct; 5(5):319-21. PubMed ID: 3791478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficiency and possibility of the use of aztreonam in bacterial infections caused by gram-negative organisms].
    Caramia G; Compagnoni L; Pettinari A; Gregorini S
    Minerva Pediatr; 1986 Sep; 38(17-18):773-7. PubMed ID: 3796535
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness and tolerability of aztreonam in urinary tract infection caused by multiresistant bacteria.
    Muzzonigro G; Minardi D; Caraceni E; Villanova A; Polito M
    Acta Urol Belg; 1987; 55(3):485-90. PubMed ID: 3661329
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of aztreonam for serious gram-negative bacterial infections.
    Raz R; Flatau E; Sudarsky M; Keness J
    Chemioterapia; 1988 Feb; 7(1):42-5. PubMed ID: 3378275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aztreonam in the treatment of urinary tract infections: a multicenter trial.
    Martelli A; Cortecchia V; Ventriglia L
    Chemotherapy; 1989; 35 Suppl 1():8-14. PubMed ID: 2659294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aztreonam in gram-negative infections in children.
    Sklavunu-Tsurutsoglu S; Gatzola-Karaveli M; Hitoglu-Makedu A; Paradelis AG; Tsurutsoglu G
    Chemioterapia; 1987 Jun; 6(2 Suppl):415-7. PubMed ID: 3509461
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of the therapeutic effects of aztreonam and ceftazidime in the treatment of complicated infections of the urinary tract].
    Orani A; Sala A; Spandri A; Levi L; Invernizzi S; Malagola G
    G Ital Chemioter; 1985; 32(2):443-7. PubMed ID: 3914433
    [No Abstract]   [Full Text] [Related]  

  • 16. [Aztreonam in urinary tract infections].
    Gioè FP; Arcara M; Gucciardi A
    Clin Ter; 1986 Jun; 117(5):399-402. PubMed ID: 3742962
    [No Abstract]   [Full Text] [Related]  

  • 17. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients.
    Rabinad E; Bosch-Perez A
    Chemotherapy; 1989; 35 Suppl 1():1-7. PubMed ID: 2659288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An Italian multicenter study on the efficacy and tolerability of aztreonam in the treatment of urinary tract infections].
    Martelli A; Cortecchia V; Ventriglia L
    Clin Ter; 1988 May; 125(3):191-201. PubMed ID: 2973940
    [No Abstract]   [Full Text] [Related]  

  • 19. [Aztreonam--new antibiotic for treating infections caused by gram-negative aerobic bacteria].
    Szymkowiak J; Fojt E
    Wiad Lek; 1993; 46(1-2):56-61. PubMed ID: 8249381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative multicenter study between aztreonam and gentamycin in the treatment of renal and urinary infections].
    Albertazzi A; Bonadio M; Fusaroli M; Miano L; Lotti T; Salvia G; Sasdelli M; Villa G; Zucchelli P
    G Ital Chemioter; 1985; 32(2):465-8. PubMed ID: 3914436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.